YARDLEY, PA--(Marketwire - November 01, 2010) - Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical company, is scheduled to participate in the following upcoming investor conferences:
2010 Credit Suisse Healthcare Conference
Friday, November 12, 2010
8:00 a.m. MT (Presentation by Eurand Chief Commercial Officer John Fraher)
2400 East Missouri Avenue
Barclays Capital Healthcare Small- and Mid-Cap One-on-One Day
Thursday, November 18, 2010
8:00 a.m. to 5:00 p.m. CT (Individual Meetings -- Time is Approximate)
Graves 601 Hotel
601 First Avenue North
An audio webcast of the Company's presentation at the Credit Suisse Conference will be available by accessing the investor relations section of www.eurand.com and will be available via replay for 30 days following the date of the presentation.
Eurand is a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary pharmaceutical technologies. Eurand has had six products approved
by the FDA since 2001 and has a pipeline of product candidates in development for itself and its collaboration partners. Its technology platforms include bioavailability enhancement of poorly soluble drugs, custom release profiles and taste-masking orally disintegrating tablet (ODT) formulations. Eurand is a global company with facilities in the U.S. and Europe. For more information, visit www.eurand.com.